Add to ORKGbactericidal activity against pneumococci. Pharmacokinetics of sparfloxacin and seru
Background: Streptococcus pneumoniae is a leading pathogen causing pneumonia, meningitis, otitis med...
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofl...
AbstractScreening by ofloxacin disk was carried out on 1158 strains of Streptococcus pneumoniae in o...
The pharmacokinetics of ciprofloxacin and sparfloxacin were simulated in vitro and the effects of ph...
Sparfloxacin is a new antimicrobial that, while maintaining a good activity against gram negative ba...
Sparfloxacin was found to display a biphask response against Escherichia coli, Staphylococcus aureus...
Previous time-kill studies have shown that RP 59500 is rapidly bactericidal against pneumococci. To ...
quinolone; ofloxacin; and sparfloxacin against In vitro activities of OPC-17116, a ne
The in vivo antichlamydial activities of sparfloxacin and reference drugs were examined in a experim...
This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the ...
The penetration of sparfloxacin into human neutrophils (PMN) and different tissue culture cells (HEp...
Antibiotic activity of escherichia coli against multiresistant staphylococcus aureu
The increasing emergence of penicillin-resistant and multiresistant strains of Streptococcus pneumon...
ObjectivesTo investigate the effects of physiologic concentrations, at alveolar level, of some fract...
Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates coll...
Background: Streptococcus pneumoniae is a leading pathogen causing pneumonia, meningitis, otitis med...
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofl...
AbstractScreening by ofloxacin disk was carried out on 1158 strains of Streptococcus pneumoniae in o...
The pharmacokinetics of ciprofloxacin and sparfloxacin were simulated in vitro and the effects of ph...
Sparfloxacin is a new antimicrobial that, while maintaining a good activity against gram negative ba...
Sparfloxacin was found to display a biphask response against Escherichia coli, Staphylococcus aureus...
Previous time-kill studies have shown that RP 59500 is rapidly bactericidal against pneumococci. To ...
quinolone; ofloxacin; and sparfloxacin against In vitro activities of OPC-17116, a ne
The in vivo antichlamydial activities of sparfloxacin and reference drugs were examined in a experim...
This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the ...
The penetration of sparfloxacin into human neutrophils (PMN) and different tissue culture cells (HEp...
Antibiotic activity of escherichia coli against multiresistant staphylococcus aureu
The increasing emergence of penicillin-resistant and multiresistant strains of Streptococcus pneumon...
ObjectivesTo investigate the effects of physiologic concentrations, at alveolar level, of some fract...
Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates coll...
Background: Streptococcus pneumoniae is a leading pathogen causing pneumonia, meningitis, otitis med...
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofl...
AbstractScreening by ofloxacin disk was carried out on 1158 strains of Streptococcus pneumoniae in o...